Rome, Italy

Olivia Befani

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivia Befani - Innovator in Allergy Treatment

Introduction

Olivia Befani is a notable inventor based in Rome, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of histamine-mediated conditions. Her innovative approach has the potential to improve the quality of life for many individuals suffering from allergies and related disorders.

Latest Patents

Olivia Befani holds a patent for "Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma." This patent describes a method of treating histamine-mediated conditions by administering an effective amount of a histaminase derived from vegetables. The conditions addressed by her invention include allergic shock, septic shock, allergic asthma, anaphylaxis, rhinitis, allergic conjunctivitis, urticaria, atopic dermatitis, and pruritus. This groundbreaking work highlights her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Olivia has demonstrated a strong dedication to research and innovation. Her work has not only contributed to her field but has also paved the way for future advancements in allergy treatment. With a focus on practical applications, she continues to explore new avenues for improving patient care.

Collaborations

Olivia has collaborated with esteemed colleagues such as Bruno Mondovi′ and Rodolfo Federico. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Olivia Befani is a pioneering inventor whose work in allergy treatment showcases her innovative spirit and dedication to improving health outcomes. Her contributions are invaluable to the medical community and those affected by histamine-mediated conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…